跳至主要内容
临床试验/ACTRN12613000982718
ACTRN12613000982718已完成未知

Investigation of alpha-lipoic acid supplementation on oxidative stress parameters in patients with schizophrenia

niversity of Belgrade, Faculty of Pharmacy0 个研究点目标入组 80 人开始时间: 2013年9月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • A ICD 10 diagnosis of schizophrenia
  • Ability to give assent
  • All patients on stable dose of antipsychotic drugs
  • Otherwise medically stable
  • Inclusion criteria for healthy controls were absence of any psychiatric and somatic disease.

排除标准

  • History of substance abuse or dependence
  • Several medical disorders: severe head injury, seizure disorders diabetes, cancer, renal or liver diseases, pregnancy
  • Oral contraceptives, hormone replacement therapy, hypolipidemic drugs, any food supplements at least 30 days before and during the study.
  • Patients clinically unstable on current medication regimen

研究者

发起方
niversity of Belgrade, Faculty of Pharmacy

相似试验

Investigation of alpha-lipoic acid supplementation... | 临床试验